Recovery & Repair · commonly explored around recovery and tissue repair
TB-500 (Thymosin β4)
TB-500 is based on thymosin beta-4, a protein that helps cells move to where repair is needed. Animal studies link it to faster wound healing and tissue recovery, and it is a staple of recovery conversations.
Informational profile
No verified OnimaChain inventory for this profile.
Also known as Thymosin beta-4 · Tβ4 · TMSB4X · Thymosin β4 (synthetic fragment)
- Sequence
- SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES
- Length
- 43 residues
- MW
- 4921.46 Da computed
- Product tags
- actin binding · thymosin · g actin sequestering
- Checked sources
- 5 sources in our record
- Structure provenance
- Sequence-derived illustration (not a measured structure)
Video intro
TB-500 (Thymosin β4) in ten seconds.
Coming soon.
Meet TB-500 (Thymosin β4)
The short version, before the deep dive.
TB-500 is based on thymosin beta-4, a protein that helps cells move to where repair is needed. Animal studies link it to faster wound healing and tissue recovery, and it is a staple of recovery conversations.
PulseChain
What’s new with TB-500 (Thymosin β4)
Section B
The quick read
Section C
Research at a glance
A simple picture of the sources we have checked. More color means more records in that category—not that the product works better.
Filled = we have checked studies of that kind · hollow = none yet · dashed = not checked yet. This is a picture of what exists, not a score.
| # | Dimension | Verified | How |
|---|---|---|---|
| 1 | Cells in a dish (in vitro) | 2 | Checked studies done on cells in a lab dish. |
| 2 | Mice | 1 | Checked studies whose title says it was done in mice. |
| 3 | Rats | 1 | Checked studies whose title says it was done in rats. |
| 4 | Other animals | 0 · none yet | Checked studies whose title names another animal. |
| 5 | People, observed | 0 · none yet | Checked studies that watched people without a controlled trial. |
| 6 | Single-person reports | 0 · none yet | Checked reports about one patient (case reports). |
| 7 | Phase I trial | 0 · none yet | Checked early safety trials in a small group of people. |
| 8 | Phase II trial | 0 · none yet | Checked mid-size trials testing whether it works. |
| 9 | Phase III trial | 0 · none yet | Checked large trials, the kind regulators look at. |
| 10 | Approved use | Not checked yet | Not checked yet — we have not connected regulator records. |
| 11 | Repeated by others | Not checked yet | Not checked yet — we do not track repeat studies yet. |
| 12 | Separate research teams | Bayrak BY · Cha HJ · Lim DS · Lachowicz JI · Gesteira TF | How many different senior authors the checked studies have. A rough stand-in for separate teams. |
| 13 | How it works | 1 | Checked studies that looked at the mechanism, based on their summary. |
| 14 | Years of research | 2020–2026 | From the oldest to the newest checked study. |
Section D
What the sources looked at
These topics come only from sources in our record. We do not add a topic just because it is popular online.
A source studied
Cell migration
Checked sources: PMID 34170491
A source studied
How cells move (actin)
Checked sources: PMID 34170491
A source studied
Wound-healing research
Checked sources: PMID 42542926, PMID 41235866
People discuss
Tissue-repair talk online
Live community feeds are not connected yet.
Section E
Why people look it up
A plain-language starting point. This is not a promise that the product will cause a result.
recovery and tissue repair
See TB-500 (Thymosin β4) beside similar names.
The Portal of Tides lets you switch between a constellation, connection view, checked-source timeline, and topic map. It uses the products already in our collection—no fake customer counts.
Section F
What the record can tell us
A product page can show what was studied. It cannot promise what will happen to a person.
What we can show
- Cell migration1 checked
- How cells move (actin)1 checked
- Wound-healing research2 checked
What we cannot promise
A lab result, animal study, online story, or product page cannot tell you what will happen to you. That question needs qualified medical guidance.
Section G
Claims people make
The big claims tied to this product. Open one to see where it came from and how it spread.
Section H
How far it has been tested
From cells in a dish, to mice, rats, bigger animals, people, proper trials, and finally regulator approval. The light stops where the checked studies stop.
cell migration
Tested as far as: Cells in a dish — and no further
- Cells in a disha checked study reached this stagereached
- Mouseno checked study has reached this stagestops here
- Ratno checked study has reached this stage
- Bigger animalno checked study has reached this stage
- Peopleno checked study has reached this stage
- Proper human trialno checked study has reached this stage
- Approved by regulatorsno checked study has reached this stage
Section I
How many separate teams
Ten papers from one lab are not ten separate confirmations.
Separate senior authors (a rough count of teams)
5 / 5 records
- Bayrak BY1 record(s)
- Cha HJ1 record(s)
- Lim DS1 record(s)
- Lachowicz JI1 record(s)
- Gesteira TF1 record(s)
Universities, funding and who cites whom: not checked yet. PubMed’s summary does not include that, so it needs another data source.
Section J
What doesn’t fit?
If a study disagrees, it goes here. We do not hide it.
No study we have checked pushes back yet
Studies that found nothing, disagree, or criticize the method will show up here once we add them. A study that only partly agrees is not the same as one that disagrees.
Section K
Timeline
What happened and when. Studies in one lane, real-world reports in another.
Research
1 event
CLAIM-TB4-CELL-MIGRATION
Claim record created
Before
— (no prior state)
After
tracked
Trials
0 events
No trial milestones are indexed to this exact record yet.
Regulatory
0 events
No regulator decisions listed yet.
Real-world reports
0 events
No real-world reports yet — social platforms are not connected.
Section L
Sources
Every study we used. Only studies we confirmed on PubMed are shown as sources. Where a drug is FDA-approved, its official label sits beside them — that is an approval, not a sales pitch.
No official FDA label for this product
We only attach an FDA record when the molecule is an approved drug and we have checked the application number. Most research peptides will stay empty here.
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
Jt Dis Relat Surg · 2026 · 8 authors · senior author Bayrak BY · doi 10.52312/jdrs.2026.2951
Checked against PubMed on 2026-09-23 · PubMed ↗
Effects of thymosin β4-derived peptides on migration and invasion of ovarian cancer cells.
Genes Genomics · 2021 · 12 authors · senior author Cha HJ · doi 10.1007/s13258-021-01127-7
Checked against PubMed on 2026-09-23 · PubMed ↗
Thymosin β4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model.
Int J Mol Sci · 2020 · 8 authors · senior author Lim DS · doi 10.3390/ijms21062166
Checked against PubMed on 2026-09-23 · PubMed ↗
Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium.
Int Immunopharmacol · 2023 · 7 authors · senior author Lachowicz JI · doi 10.1016/j.intimp.2023.109743
Checked against PubMed on 2026-09-23 · PubMed ↗
Engineered Tandem Thymosin Peptide Promotes Corneal Wound Healing.
Invest Ophthalmol Vis Sci · 2025 · 6 authors · senior author Gesteira TF · doi 10.1167/iovs.66.14.31
Checked against PubMed on 2026-09-23 · PubMed ↗
The building blocks, one by one
| # | Code | Residue | Class | Chirality | Features |
|---|---|---|---|---|---|
| 1 | S | Serine | polar | L | |
| 2 | D | Aspartate | negative | L | |
| 3 | K | Lysine | positive | L | |
| 4 | P | Proline | special | L | Proline kink |
| 5 | D | Aspartate | negative | L | |
| 6 | M | Methionine | hydrophobic | L | |
| 7 | A | Alanine | hydrophobic | L | |
| 8 | E | Glutamate | negative | L | |
| 9 | I | Isoleucine | hydrophobic | L | |
| 10 | E | Glutamate | negative | L | |
| 11 | K | Lysine | positive | L | |
| 12 | F | Phenylalanine | hydrophobic | L | |
| 13 | D | Aspartate | negative | L | |
| 14 | K | Lysine | positive | L | |
| 15 | S | Serine | polar | L | |
| 16 | K | Lysine | positive | L | |
| 17 | L | Leucine | hydrophobic | L | |
| 18 | K | Lysine | positive | L | |
| 19 | K | Lysine | positive | L | |
| 20 | T | Threonine | polar | L | |
| 21 | E | Glutamate | negative | L | |
| 22 | T | Threonine | polar | L | |
| 23 | Q | Glutamine | polar | L | |
| 24 | E | Glutamate | negative | L | |
| 25 | K | Lysine | positive | L | |
| 26 | N | Asparagine | polar | L | |
| 27 | P | Proline | special | L | Proline kink |
| 28 | L | Leucine | hydrophobic | L | |
| 29 | P | Proline | special | L | Proline kink |
| 30 | S | Serine | polar | L | |
| 31 | K | Lysine | positive | L | |
| 32 | E | Glutamate | negative | L | |
| 33 | T | Threonine | polar | L | |
| 34 | I | Isoleucine | hydrophobic | L | |
| 35 | E | Glutamate | negative | L | |
| 36 | Q | Glutamine | polar | L | |
| 37 | E | Glutamate | negative | L | |
| 38 | K | Lysine | positive | L | |
| 39 | Q | Glutamine | polar | L | |
| 40 | A | Alanine | hydrophobic | L | |
| 41 | G | Glycine | special | L | flexible |
| 42 | E | Glutamate | negative | L | |
| 43 | S | Serine | polar | L |
